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ABSTRACT 
Aims Rapid and efficient magnetization of human bone marrow stromal cells (BMSC) 
through functionalized magnetic nanoparticles (MNP). 
Methods MNP were functionalized with poly(epsilon-lysine) dendrons exposing 
carboxybetaine residue (CB-MNP) to enhance binding to the cellular glycocalix. BMSC were 
incubated with CB-MNP or non-functionalized PAA-MNP for 5-30 minutes in suspension. 
Results CB-MNP functionalisation increased the magnetization efficiency by 3-fold. 
Remarkably, 66% of cells were magnetized after only 5 minutes and the maximum efficiency 
of >80% was reached by 15 minutes. BMSC viability, proliferation and differentiation were 
not impaired: actually, adipogenic and osteogenic differentiation were even improved. 
Conclusions Carboxybetaine-dendron functionalization ensured rapid and efficient BMSC 
magnetization and allowed innovative suspension labelling, with a potential for bypassing 
adhesion culture of progenitors for regenerative medicine. 
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INTRODUCTION 
Cell-based therapies aim at regenerating fully-functional tissues damaged by surgery, 
trauma or disease, where their spontaneous repair is insufficient or leads to non-physiological 
healing [1]. Tissue engineering, based on the combination of suitable progenitor cells with 
biocompatible scaffolding materials, is the most advocated strategy as it enables both control 
over cell behaviour and retention upon transplantation [2,3]. 
Mesenchymal stem/stromal cells (MSC) are widely accepted as the best candidates in this 
type of regenerative medicine approach as they are able to differentiate into the three main 
mesenchymal lineages reaching complete differentiation both in vitro and in vivo, particularly 
into cells of the musculoskeletal system [4]. Therefore, this phenotypic plasticity encourages 
its main therapeutic application in the regeneration of damaged bone or cartilage, where the 
clinical demand is not met by satisfactory surgical solutions [2,5–7]. Studies of MSC obtained 
from different sources show that those isolated from bone marrow (Bone Marrow Stromal 
Cells, BMSC) possess a greater ability to differentiate into the osteogenic lineage both in vitro 
and in vivo when compared to MSC derived from other tissues [8–11]. The use of MSC for 
bone regeneration can be optimized in a tissue engineering approach where these cells are 
combined with natural or synthetic matrices able to mimic the extracellular matrix of 
connective tissue, hence favouring the differentiation of either host migrating progenitors or 
transplanted cells [3,12]. In the latter case, an optimal seeding of the progenitor cells is the 
required first step to ensure a homogeneous regeneration of the tissue throughout the scaffold. 
In particular, high seeding density and uniform cell distribution through the scaffold are 
critical to promote homogenous tissue formation and achieve clinical success [13]. 
Bioreactors, including spinner flasks and perfusion bioreactors, are a very effective 
technology to reach this goal and can overcome the limitations of static loading of highly 
concentrated cell suspensions [14]. However, bioreactor-based seeding procedures require 
one or more days of in vitro culture to allow cell distribution and attachment to the scaffolds 
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[15]. On the other hand, it is highly desirable from a clinical point of view to develop 
intraoperative approaches, whereby progenitors are harvested, seeded onto the scaffold and 
re-implanted into the patient directly without an in vitro culture step; this allows the operator 
to minimize the negative effects of cell manipulation [16] and to reduce costs for cell 
expansion under GMP manufacturing conditions [17,18]. 
Magnetic forces capable of driving cells through the 3D scaffold mesh could provide an 
attractive means to achieve its rapid and homogenous seeding [19]. It has been suggested that 
this magnetic drive can be achieved through the coupling of cells to superparamagnetic nano-
particles (MNP). MNP (from 5 to 150 nm in diameter) can be engineered to have their 
magnetic core coated with different polymeric materials, including dextran, polylysine, 
chitosan or silica [20,21]. The application of these coatings does not alter the magnetic 
properties of the MNP, but enhances their biocompatibility and promote their endocytosis, a 
step necessary to the final magnetization of the cells [22]. However, cell labelling with MNP 
is a slow and low-yield process often not able to guarantee levels of magnetization sufficient 
for cell manipulation. Indeed, published data show that it is necessary to incubate MNP in 
vitro on adherent cells for prolonged periods of time, ranging between 12 and 24 hours [23–
26]. This is a limitation that currently precludes the use of magnetized cells in most 
biomedical applications. 
This work reports a novel method based on the surface functionalization of MNP with 
biocompetent dendrons that significantly accelerates and improves the magnetization of 
human BMSC. The interaction between MNP coated by a thin layer of poly(acrylic acid) 
(PAA) and BMSC was achieved through the surface functionalization of the PAA coating 
with hyperbranched poly(epsilon-lysine) dendrons, the uppermost branching generation of 
which was tethered with the zwitterionic modified amino acid carboxybetaine. It was 
hypothesized that the high-density presentation of this highly hydrophilic amino acid could 
favour the interaction between the MNP and the cell surface glycocalyx, thus enhancing MNP 
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internalization. The significantly improved labeling efficiency of cells by functionalized MNP 
enabled the establishment of a novel culture-free protocol of BMSC magnetization that 
ensures their rapid and highly efficient magnetization in suspension, while preserving their 
differentiation potential, thereby enabling the possibility to bypass adhesion culture of 
mesenchymal progenitors. 
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MATERIALS AND METHODS 
Dendron Synthesis 
Poly (ε-lysine) dendrons of three (Gen3K) branching generation type were synthesised on a 
Tenta Gel S (-NH2) resin (Iris Biotech GmbH, Germany) using a previously reported 9-
fluorenylmethoxycarbonyl (Fmoc) solid phase peptide method based on the sequential 
addition of Fmoc-protected amino acids [27]. Dendrons were designed with a cysteine as core 
molecule. The resin was placed inside a reaction vessel and swollen in N, N – 
dimethylformamide (DMF) (Fisher Scientific UK) for 15 minutes. After washing with 3 x 7 
cm3 DMF, the addition of an acid labile Rink amide linker (Iris Biotech GmbH, Germany) to 
the resin was undertaken via the C-terminal of the linker. The Rink amide linker was added to 
allow the final cleavage of the product from the resin. The exposure of N-terminal amines 
allowed the final assembly of the carboxybetaine molecule tethering the uppermost branching 
generation. The obtained dendrimer [C-Gen3K(CB)16] was allowed to stand for 30 minutes 
for a final deprotection step in 20 % v/v piperidine (Sigma Aldrich Co. Ltd, UK) in DMF and 
washed with 3 x 7 cm3 DMF. The contents of the reaction vessel were then washed with 40 
cm3 dichloromethane (Fisher Scientific, UK), methanol (Fisher Scientific, UK) and 
diethylether (Fisher Scientific, UK). Then, the product of synthesis was dried and weighed 
prior to be cleaved from the resin. After three hours incubation, the solution was passed down 
a Pasteur pipette filled with 1 cm of a glass wool and the crude peptide was collected in a tube 
containing 20 cm3 of chilled diethylether. The solution was then centrifuged (Denley BS400) 
at 3500 rpm for 5 minutes to collect the dendron. The diethylether was then carefully 
decanted from the tube and fresh diethylether 20 cm3 was added and the sample was vortexed 
to disrupt the peptide pellet. The centrifugation procedure was then repeated twice more and 
the diethylether was subsequently decanted off. The reaction product was then freeze dried 
(Christ Alpha2-4), dissolved in ethanol and filtered through a syringe filter with a pore 
diameter of 0.22 µm (GE Healthcare Amersham, UK) prior to characterisation. 
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Dendron Characterisation 
Once synthesised the dendron was characterised by analytical HPLC to determine purity and 
further purified by further by preparative HPLC. microTOF mass spectrometry was used to 
characterize the dendron. The crude peptide was separated by a standard analytical HPLC 
method (WatersTM 717 plus Autosampler) performed on a hydrophobic RP 18 column 
(150x4.60 mm, Luna 3u C18 100A, Phenomenex) at 25° C (Column chiller Model 7955, 
Jones Chromatography). The mobile phase consisted of a stepwise gradient of two solvent 
systems (Solvent A deionised water with 0.1% v/v TFA, Solvent B acetonitrile with 0.1% v/v 
TFA). Chromatograms were recorded on UV detector (SPO-6A, Shimadzu) and analysed by 
HPLC software, Total Chrom-TC Navigator. 
 
Attachment of Dendron to Fe3O4@PAA MNP  
Fe3O4@PAA super magnetic nanoparticles were produced by Nanogap S.L. (Santiago de 
Compostela, Spain) as previously described [23]. Fe3O4@PAA (13 mg) were washed three 
times with 20 ml of ethanol. A 20 ml volume of 0.1 M MES buffer containing 38 mg EDC 
and 6 mg NHS was added, the solution was vortexed for 30 seconds and then placed in the 
shaking incubation for 30 minutes.  L-cysteine (25 mg, 0.2 mM) was added and the mixture 
was shaken for 1 h. The MES buffer was removed and the beads washed three times with 
ethanol. The beads were then split into two tubes. To conjugate the dendrimers to the cysteine 
via a disulfide bridge, 10 ml of 8 M urea containing 3% w/v hydrogen peroxide were added 
along with (i) 5.3 mg, 1 µmole dendrimer. The tubes were then returned to the shaking 
incubator for 30 minutes. Non functionalized and dendron-functionalized PAA-MNP [PAA-
MNP-C-Gen3K(CB)16] were characterized by FTIR to show the successful 
biofunctionalization of the MNP. Each sample was examined using FTIR-ATR (Nicolet) 64 
scans, 1 cm-1 resolution in the range 4000-650 cm-1. All samples were washed three times in 
	 8 
ethanol for disinfection, dried by evaporation under sterile conditions and stored at 4° C until 
used. 
 
BMSC culture 
Bone marrow (BM) aspirates were obtained from four healthy donors of similar age (35, 
36, 37 and 44 years old, 3 male and 1 female), during routine orthopaedic surgical procedures, 
in accordance with the local ethical committee (Ref. Nr. EK:78/07) and after informed 
consent. Bone marrow nucleated cells (BMNC) were isolated as previously described [28]. 
Briefly, BM was diluted 1:10 with phosphate-buffered saline (PBS) (Sigma-Aldrich, Saint 
Louis, MO) and nucleated cells were counted after staining with crystal violet solution 0.01% 
(Sigma Aldrich, Saint Louis, MO). BMNC were then seeded in tissue culture dishes at a 
density of 1x105 cells/cm2. 
BMSC were expanded in complete medium (CM), consisting of α-MEM supplemented 
with 10% foetal bovine serum (FBS), 1% HEPES, 1% Sodium pyruvate and 1% Penicillin-
Streptomycin-Glutamin (100x) solutions (all from Gibco, Life Technologies, Switzerland), 
and conditioned with 5 ng/ml FGF-2 (R&D systems, Minneapolis, MN) [29]. At a sub-
confluent density of about 80%, cells were washed once with PBS, detached using 0.05% 
trypsin (Gibco) for 5 min at 37° C and counted to assess the number of population doublings. 
BMSC were then plated at a density of 3x103 cells/cm2 for further in vitro expansion in tissue 
culture dishes (TPP, Trasadingen ,Switzerland). 
 
Flow cytometry 
For phenotypic characterization of BMSC, cells were incubated for 20 minutes on ice, in 
PBS with 5% BSA. The antibodies used were: CD90-FITC, CD73-PE, CD45-FITC, IgG1-
FITC, IgG1-PE (all from Becton, Dickinson and Company, Franklin Lakes, NJ) and CD105-
FITC (Serotec Ltd. Oxford, UK). All the antibodies were used at a dilution of 1:50, except 
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CD105-FITC, which was used at 1:20. Data were acquired with a FACSCalibur flow 
cytometer (BD Biosciences) and analyzed by using FlowJo software (Tree Star, Ashland, OR, 
USA). 
 
Labeling of BMSC with CB-MNP 
In order to obtain a starting reference concentration of 7 mg/ml, 3.5 mg of CB-MNP and 
PAA-MNP magnetic nanoparticles were resuspended in 500 µl of 100% ethanol. To improve 
bead disaggregation, microcentrifuge tubes were placed in an ultrasonicating bath for 1 hour, 
vortexing them every 10 minutes to allow for complete resuspension. In a 50 ml tube, BMSC 
were resuspended in an appropriate volume of CM to reach a final concentration of 4x104 
cells/ml. Three different concentrations of both magnetic nano-particles were tested, 
respectively: low = 7.2 µg/104 cells, medium = 14.4 µg/104 cells and high = 28.8 µg/104 cells. 
The magnetic nanoparticles were added to cell suspension and incubated at 37°C, 5% CO2 on 
an orbital shaker (100 rpm) for 5, 15 min or 30 minutes (2 replicates/donor for 3 independent 
donors, n=6 for each condition). 
At the end of the incubation, efficiently labelled MSC were separated by application of an 
external magnet on the side of the vertically held tube for 10 minutes, so that magnetic force 
would not coincide with gravity. After labeling the non-magnetized cells were collected in a 
new tube to be separated from the magnetized ones. Both cell subpopulations were 
centrifuged for 5 minutes at 1500 rpm and counted to determine the percentage of magnetized 
cells. Magnetized cells were resuspended in CM and seeded in tissue culture dishes for further 
analyses. 
 
Cytotoxicity assay 
In order to determine whether magnetic labeling was toxic, labeled cells were seeded in 
six-well plates (TPP) at a density of 6x105 cells/cm2 (3 wells/donor for 2 independent donors, 
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n=6 for each condition). After 1, 2 and 3 days medium was discarded and cells were 
incubated with Propidium Iodide (PI) solution (diluted 1:20 in CM; Sigma Aldrich) for 20 
minutes at 37° C, 5% CO2. At the end of the incubation, fresh medium was added and images 
of ten random fields for condition were acquired (Olympus IX50 con camera Color View 
Olympus) both in brightfield and using a red fluorescent filter. Live and PI-positive cells were 
counted and the results were expressed as the percentage of viable cells. 
 
In vitro proliferation 
After labeling, magnetized BMSC were seeded in T75 tissue culture flasks at the density of 
3x105 cell/cm2 (2 flasks/donor for 3 independent donors, n=6 for each condition) and they 
were expanded for two further passages. The number of population doublings was calculated 
at each passage according to formula: Log2 (N/ N0)/t, where N is the number of cells obtained 
after x days, N0 is the number of cells seeded at time 0, and t is the time between two 
passages. 
 
Trasmission Electron microscopy 
Labeled BMSC were seeded on glass coverslips for six hours and then the samples were 
fixed with 2.5% glutaraldehyde in 0.1 M cacodylate buffer pH 7.6 for 1 h at room 
temperature. After post-fixation with 1% OsO4 in cacodylate buffer for 1 h, cells were 
dehydrated in an ethanol series and embedded in Epon resin. Ultrathin sections stained with 
uranyl acetate and lead citrate were observed with a Jeol Jem-1011 transmission electron 
microscope (Jeol Jem, USA). Two hundred nuclei were examined for each sample. In order to 
quantify the number and the size of magnetic nanoparticle aggregates that had been 
internalized by each cell, the area occupied by magnetic nanoparticles was identified using 
region of interests (ROI) tool and successively calculated by the software (Nis D 4.10 
software from Nikon, Amsterdam, Netherlands). 
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Confocal scanning microscopy 
After labeling, BMSC were seeded on glass coverslips and allowed to adhere overnight. 
After three washes in PBS, the cell monolayer was fixed with 4% PFA at room temperature 
(RT) for 20 min. Non-specific sites were blocked with 1% Bovine Serum Albumin (BSA, 
Sigma Aldrich) in PBS for 30 minutes at RT. Fixed cells were incubated with a primary 
antibody against CD90 (clone 5E10, Abcam, 1:50 in blocking solution) overnight at 4° C in 
humid chamber. After three washes in PBS for 5 minutes, Cy3-conjugated anti-mouse IgG 
(1:100 in PBS 1X Sigma-Aldrich) secondary antibody was added and incubated for 1 hour at 
RT. After three washes in PBS, coverslips were mounted in Fluoromount-G solution and 
imaged. A confocal laser scanning microscopy analysis of intracellular localization of MNP 
was performed using a Nikon TiE microscope equipped with a fully automated A1 confocal 
laser which incorporates the resonant scanner with a resonance frequency of 7.8 kHz allowing 
high-speed imaging (A1R, Nikon, Amsterdam, Netherlands). Reflection and fluorescence 
modes were applied sequentially for detection of MNP and CD90 signal, respectively. In 
reflection mode, the sample was excited with a 488 nm laser: light reflected by the MNP 
passed through a beam splitter (20/80), was reflected by a 450/50 nm filter and was detected 
by a photomultiplier. The CD90 signal was instead detected by fluorescence emission of the 
Cy-3 fluorophore after excitation by 561 nm laser light. Z-stack acquisition (0,22 nm and 0,13 
nm single step respectively for PAA-MNP and CB-MNP) was performed and the confocal 
pinhole was set to 1.2 Airy disk and a 60X Plan-Apochromatic PhN2 1.4NA objective lens 
was used. Orthogonal projection was applied to evaluated MNP position in relation to cell 
membrane. Ten images per condition were analysed (n = 10). 
 
In vitro Osteogenic Differentiation 
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Osteogenic differentiation was induced in monolayer as previously described (Jaiswal, et 
al., 1997). Briefly labeled BMSC were seeded in 6-well plates (8 wells/donor from 2 
independent donors, 4 of which used for Alizarin Red staining and 4 for calcium 
quantification; n=8 for each condition and assay) at a density of 3x105 cells/cm2 in α-MEM 
supplemented with 10% FBS until they reached confluency. Medium was then supplemented 
with 10 mM β-glycerophosphate, 10 nM dexamethasone and 0.1 mM L-Ascorbic acid-2-
phosphate (all from Sigma) for three weeks (Osteogenic medium, OM) and changed twice per 
week. After 21 days of osteogenic induction, the cell layer was washed once with PBS, fixed 
with 4% formalin for 10 min at room temperature and rinsed extensively with distill H2O. 
Cells layer was incubated with 2% Alizarin red (AR-S Sigma Aldrich) solution for 10 min at 
room temperature and when the solution was removed plates were washed twice with 100% 
ethanol and images were acquired using a phase-contrast microscope (Olympus IX50 with a 
Color View camera). The total calcium amount was quantified using the Calcium 
quantification kit CA-590 (RANDOX, Crumlin, United Kindom). Briefly, at the end of 
osteogenic induction the cell monolayer was washed twice with PBS and scratched adding 0.5 
N HCl in each well. Cell lysates were transferred in microcentrifuge tubes and were shaken 
for 3 hours at 4° C on an orbital shaker. At the end of the incubation the solution was spun at 
1000 rpm for 5 minutes. The supernatant was collected in a new tube and stored at -20° C 
until the analysis. The working solution was prepared adding equal parts of the two 
components R1 (calcium buffer) and R2 (Calcium chromogen). In a 96-well plate, 5 µl of cell 
lysate were added to 195 µl of working solution and absorbance was read at 575 nm. A 
standard curve was prepared using Calcium/Phosphate at 5 different concentrations between 
0-100 µg/ml. 
 
In vitro Adipogenic Differentiation 
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Adipogenic differentiation was induced as previously described [31]. Briefly, cells were 
seeded in 6-well plates at a density of 3x105 cells/cm2 (4 wells/donor from 2 independent 
donors, n=8 for each condition) and cultured in CM until confluence. The medium was then 
supplemented with 10 µg/ml Insulin, 1 µM Dexamethasone, 100 µM indomethacin and 500 
µM 3-isobutyl-1-methyl-xanthine (adipogenic induction medium, AIM) for 72 hours and 
subsequently combined with 10 µg/ml insulin (all from Sigma Aldrich) (adipogenic 
maintenance medium, AMM) for 24 hours. The 96-hour treatment cycle was repeated four 
times. At the end of adipogenic induction, the cell monolayer was washed with PBS, fixed in 
4% formalin for 10 minutes and stained with three volumes of Oil Red O (Sigma Aldrich) in 
0.3% v/v isopropanol and two volumes of H2O for 15 minutes at room temperature. 
Representative micrographs were acquired using a brightfield microscope (Olympus IX50 
with a Color View camera). Oil Red O, contained in lipid droplets, was then solubilized with 
100% isopropanol and the optical density was measured with a spectrophotometer at 500 nm 
[32]. 
 
Statistical Analysis 
Results are expressed as mean ± SEM. Before statistical testing, Kolmogorov-Smirnov test 
was performed on all data sets to assess normal distribution. The data reported in Figure 6 did 
not satisfy the normality test and were therefore analyzed with the non-parametric Kruskal-
Wallis test for multiple comparisons and Dunn’s post-hoc test. All other data sets passed the 
normality test and were therefore analysed using 1-way ANOVA and Bonferroni’s multiple-
comparison test as a post-test. Results were considered to be statistically significant at p 
values < 0.05 (* = p < 0.05, ** = p < 0.01, *** = p < 0.001). The data, including median value 
with range or mean value with SEM, were processed with GraphPad Prism 5 Software 
(GraphPad; San Diego, CA, USA). 
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RESULTS 
Dendrimer synthesis and MNP functionalization 
Mass spectrometry confirmed the successful synthesis of dendrons with peaks 
corresponding to various charged peptides, all multiples of the theoretical molecular weight 
(M): 3644.6. These corresponding peaks were: M12+ m/z 303.84, M9+ m/z 405.11, (M+11H)11+ 
m/z 332.41, (M+9H)9+ m/z 406.12, (M + 4H)4+ m/z 912.52. 
The final yield of the reaction was 50 mg of dendrimers from an initial 100 mg of solid-
phase resin, with a purity of 63%, corresponding to a single HPLC peak eluted at 14 min. 
Figure 1A summarizes the structure of MNP functionalized with the hyperbrached 
poly(epsilon lysine) dendrons. Fe3O4 magnetic nanoparticles were coated with a thin layer of 
polyacrilic acid (PAA-MNP) and successively functionalized with dendrons of poly(epsilon 
lysine) to yield PAA-MNP-C-Gen3K(CB)16, which will be referred to as CB-MNP in the rest 
of the manuscript for simplicity. PAA-MNP and CB-MNP were characterized for Fourier 
Transform Infrared Spectroscopy (FTIR). Functionalized CB-MNP showed the typical amine 
I and amine II peaks of the dendrons (Figure 1B, red arrows) in the region comprised between 
1400 cm-1 and 1600 cm-1, which were instead not found in the non-modified PAA-MNP 
(Figure 1C). The size of non-functionalized PAA-MNP nanoparticles was 18.46 nm with a 
zeta potential of –45.6 mV and the functionalization with dendrons led to an increase in the 
measured hydrodynamic radius to 33.37 nm and a zeta potential of –25.6 mV (Meikle et al, 
manuscript submitted). 
 
Dose-dependent cytotoxicity and labelling efficiency of functionalized CB-MNP 
Phenotypic characterization of isolated BMSC confirmed that the populations were almost 
uniformly positive for mesenchymal markers (CD105 = 97.8±0.8%, CD90 = 81.3±8.0% and 
CD73 = 98.9±0.4%) whereas the presence of leukocytes was extremely infrequent (CD45 = 
0.5±0.2%), in agreement with previous results [28,33,34]. 
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In order to minimize manipulation of isolated BMSC, we developed a protocol to rapidly 
label cells in suspension rather than in adhesion culture (Figure 2A). Cells were re-suspended 
in a 50-ml tube in complete culture medium, in order to avoid serum deprivation during the 
labelling procedure, at a concentration of 4x104 cells/ml and MNP were added (step1). 
Labelling took place during a 30-minute incubation on an orbital shaker to avoid 
sedimentation of cells and MNP (step 2). Efficiently labelled MSC were then separated by 
application of an external magnet on the side of the vertically held tube, so that magnetic 
force would not coincide with gravity (step 3), and isolated cells were plated on tissue culture 
dishes for further analyses (step 4). 
To investigate which CB-MNP concentration could preserve cell viability while bestowing 
a magnetization level sufficient for manipulation, increasing concentrations of CB-MNP were 
tested with a fixed number of target cells. A starting concentration of 14.4 µg CB-MNP/104 
cells (medium concentration) was calculated from published experiments performed using a 
different protocol on adherent cells [35], transforming the amount reported there in µg of 
MNP/104 cells, to be incubated in suspension labeling in a standard volume. Starting from this 
reference dose, which was shown to produce efficient magnetization with multi-hour 
incubations on adherent cells, 2-fold lower and higher concentrations were included (low = 
7.2 µg CB-MNP/104 cells and high = 28.8 µg CB-MNP/104 cells). After magnetic separation, 
labelling efficiency was measured by counting the cells retained by the magnet compared to 
the total number before the incubation. After 30 minutes of incubation with CB-MNP, >80% 
of the cells were successfully magnetized at all three tested concentrations (low=82.7±7.9%, 
medium=85.5±4.0%, high=85.0±2.8%, p not significant for all comparisons), indicating that 
the labelling conditions were saturating in this range. Cells were then allowed to adhere to 
plastic at 37°C for 24 hours. Labelling was clearly visible under transmitted light and it did 
not affect the morphology and the adherence properties of the cells. CB-MNP formed 
macroscopic aggregates, which appeared mainly localized on the cell membrane at this stage 
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(Figure 2B, red arrows). Interestingly, CB-MNP that were not associated with cells could be 
seen to form much smaller aggregates (Figure 2C, white arrows), suggesting a reduced 
propensity for spontaneous aggregation. A cytotoxicity test was performed 24, 48 and 72 
hours after labelling. Viability was always close to 99% with all CB-MNP doses at all time-
points and did not differ from that of unlabelled control MSC (Figure 2D). Taken together, 
these results indicate that a 4-fold range of CB-MNP doses allowed rapid and efficient 
magnetization of human BMSC without signs of cytotoxicity. 
 
Effect of magnetic labeling with CB-MNP on MSC proliferation 
After labelling with the different CB-MNP doses and magnetic separation, BMSC were 
plated at low density to measure the possible effects of CB-MNP on active cell proliferation. 
Before reaching confluence the cells were detached and counted (Passage 1), re-plated at low 
density and counted again after a further passage to determine the number of population 
doublings (Passage 2). Proliferation was slower at the second passage compared to the first, as 
primary BMSC are well-known to gradually reduce their doubling time over the first few 
passages in culture [29,36]. However, no significant differences were found in the number of 
doublings per day between the different CB-MNP doses and in comparison with control 
conditions, at both passages (Figure 3), indicating that CB-MNP labelling did not interfere 
with BMSC adhesion and proliferation capacity. 
 
Adipogenic and osteogenic differentiation potential of BMSC after CB-MNP labelling 
To determine the effects of labelling with the different CB-MNP doses on BMSC 
differentiation potential, after magnetic separation cells were expanded on tissue culture 
plastic for one passage and then treated with adipogenic or osteogenic differentiation-
inducing factors. 
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Under adipogenic conditions, both control and CB-MNP-labeled MSC generated mature 
adipocytes (Figure 4A), characterized by mature lipid vacuoles revealed by Oil Red O 
staining. Quantification of the amount of lipid deposition after Oil Red O extraction showed 
that differentiation of cells labelled with all CB-MNP concentrations was improved by about 
30% compared to that of unlabelled control BMSC (Figure 4B). 
Following osteogenic stimulation, BMSC differentiated efficiently under all conditions, as 
evidenced by the production of Alizarin Red-positive calcium deposits in vitro (Figure 5A). 
Since Alizarin Red staining provides only semi-quantitative results, osteogenic differentiation 
was precisely measured by biochemical quantification of the deposited calcium after lysis of 
the cell layers, revealing that labelling with all three doses of CB-MNP significantly increased 
osteogenic differentiation by more than 2-fold compared to control naïve cells (Figure 5B). 
 
Rapid magnetization of BMSC by CB-MNP 
In any biomedical or biotechnological application involving the use of MSC, it is desirable 
to minimize the duration of the labelling procedure without compromising the efficiency of 
the whole operation. Therefore, in order to determine the minimum necessary duration of 
labelling, BMSC were incubated with the lowest of the three previously tested doses of CB-
MNP (7.2 µg/104 cells), since this already ensured the maximum labelling efficiency and the 
percentage of magnetized cells was measured after incubation for 5, 15 and 30 minutes and 
compared with the same dose of non-functionalized PAA-MNP to determine the effect of the 
dendron C-Gen3K(CB)16. As shown in Figure 6, labelling with PAA-MNP led to a 
magnetization efficiency of 27.9±10.9% after 5 minutes of incubation, which did not improve 
with longer labelling times up to 30 minutes (21.3±12.1% and 23.4±6.8% for 15 and 30 
minutes respectively, p=n.s.). However, CB-MNP could efficiently magnetize already 
66.2±14.4% of cells with only 5 minutes of incubation and labelling efficiency increased to 
79.0±6.7% and 83.7±6.8% after 15 and 30 minutes respectively. Therefore, functionalization 
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with C-Gen3K(CB)16 led to an increase of 2.4-fold in the BMSC magnetization efficiency by 
PAA-MNP (p<0.001) with an incubation time as rapid as only 5 minute. 
 
Effect of CB functionalization on PAA-MNP internalization 
In order to determine the fate of MNP after cell labelling, MSC were incubated with the 
lowest dose (7.2 µg/104 cells) of CB-MNP or PAA-MNP for 5 and 30 minutes and the 
localization of MNP was analysed by confocal microscopy and transmission electron 
microscopy (TEM) after adhesion to coverslips, washing of unbound particles and fixation 
(overnight for confocal analysis and 6 hours for TEM). For confocal microscopy, the cell 
membrane was marked by immunostaining for the BMSC surface marker CD90 (in red in 
Figure 7), while MNP were visualized in the green channel taking advantage of the intrinsic 
property of iron-containing MNP to reflect fluorescent light. Both types of MNP could be 
clearly seen on the internal side of the BMSC cell membrane in the orthogonal projections of 
confocal z-stacks. However, while rarely some PAA-MNP clusters could be observed also 
attached to the cell surface outside the membrane, possibly in the act of being internalized 
(Figure 7B), functionalized CB-MNP appeared almost exclusively internalized (Figure 7A). 
To more rigorously determine how CB functionalization may affect the cell binding and 
internalization processes, samples were analysed by TEM (Figure 8). After incubation for 
either 5 or 30 minutes, both kinds of MNP were visible inside cytoplasmic vacuoles as well as 
in extracellular aggregates (arrowheads and arrows, respectively, in Figure 8A-E). However, 
in agreement with the confocal results, cells treated with CB-MNP showed smaller and less 
dense extracellular aggregates than those labelled with non-functionalized PAA-MNP. The 
vacuoles containing MNP aggregates were identified as early endosomes because of their 
electron-clear inner volume. Apart from the increased number of vacuoles, cells labelled with 
both kinds of MNP did not show any ultrastructural signs of cytotoxicity, as the morphology 
of the nucleus, mitochondria, Golgi apparatus and endoplasmic reticulum was normal and 
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similar to that of unlabelled control BMSC. The size and the number of intracellular MNP 
aggregates were quantified. As shown in Figure 8F, the size of internalized aggregates was 
quite variable, but on average it was similar between CB- and PAA-MNP after 5-minute 
incubation. However, aggregates of non-functionalized PAA-MNP became significantly 
larger after 30 minutes of incubation, whereas those of functionalized CB-MNP remained 
smaller. Further, labelling with CB-MNP led to a much greater number of internalized 
aggregates per microscopic field than non-functionalized PAA-MNP after incubation for both 
5 and 30 minutes (3- and 6-fold more, respectively; Figure 8G). Taken together, these data 
suggest that carboxybetaine dendron functionalization significantly improved the efficiency 
of MNP adhesion to cell membrane and their subsequent internalization in the form of many 
small aggregates. 
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DISCUSSION 
The present work describes a novel approach for the magnetization of multipotent 
mesenchymal progenitors based on the combination of: a) superparamagnetic nanoparticles 
functionalized with a hyperbranched dendron coating, exposing a highly hydrophilic 
carboxybetaine residue and designed for efficient interaction with the glycocalyx on cell 
membranes; and b) an optimized protocol for cell labelling in suspension, avoiding the step of 
adhesion culture. The combination of these two elements enabled the rapid (15 minutes) and 
efficient (>80%) magnetization of primary human BMSC with no impairment of their in vitro 
viability and proliferation, while their differentiation potential was even improved. 
Magnetization of cells has been long considered as a suitable approach towards their 
separation, particularly in the field of cytofluorimetry. Cell sorting is achieved by the 
coupling of micron-size magnetic beads to antibodies that are able to bind specific cell surface 
molecules and separate the expressing cells from a heterogeneous sample through magnetic 
forces [37]. However, such approach is not suitable for other biotechnological and biomedical 
applications where, for example, magnetic forces can be used to manipulate heterogeneous 
progenitor populations, whose surface marker composition is only partially known, such as in 
tissue engineering/regenerative medicine applications. Therefore, the availability of super-
paramagnetic particles of nanoscale size that can be internalized by most cells and that are 
activated only in the presence of a magnetic field have opened new avenues for the 
exploitation of magnetism in a number of biotechnological and biomedical applications. This 
new technological approach has also expanded the possibilities for non-invasive analysis of 
progenitor fate after their in vivo delivery, such as by magnetic resonance imaging (MRI) 
[38]. While MNP internalization enables the magnetization of any type of cells, concerns still 
remain about their potential cytotoxic and genotoxic effects. Towards this end, the coating of 
MNP with biocompatible materials has been proposed; these mainly include synthetic and 
natural polymers. However, the selection of these polymers has been rather based on the 
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demonstration of their biocompatibility in other applications and no reported study has been 
based on an ad hoc design of coatings where the polymer can be exploited to enhance not 
only the MNP biocompatibility, but also their internalization process. 
In this study a unique functionalization approach has been designed that capitalises on the 
availability of highly homogeneous MNP coated with a 2-nm layer of poly(acrylic acid) [39]. 
The presence of the exposed carboxylic groups of the polymer at the surface of this type of 
MNP was exploited to covalently graft a novel class of hyperbranched poly(epsilon-lysine) 
peptides. These peptides, called dendrons, present sixteen uppermost molecular branches, all 
functionalised with carboxybetaine, a highly hydrophilic amino acid derivative [40]. The 
successful synthesis of a highly purified dendron was proven both by the single HPLC elution 
peak released at 14min and by the mass spectrometry showing peaks matching the multiples 
of the theoretical molecular weight of the dendron. 
As expected, the thin poly(acrylic acid) coating of the MNP could not be detected by FTIR 
as its thickness was below the sensitivity limit of the instrument. The weak, near-to-
background footprint of the branched peptide could be however detected when dendron-
functionalised MNP were analysed. In particular, the wavelength range between 1000 and 
1600 cm-1 showed at least 4 peaks that can be attributed to the primary and secondary amines 
present both in the poly(epsilon lysine) dendron core and in the terminal carboxybetaine [41]. 
These results were also corroborated by the presence of a large peak in the region ranging 
between 3000 and 3500 cm-1 that can be attributed to both the presence of amino groups and 
hydroxylic groups of water molecules bound by the highly hydrophilic carboxybetaine when 
exposed to air humidity [40]. The increased hydrophilicity of functionalized CB-MNP was 
also confirmed by work published elsewhere showing that the measured hydrodynamic radius 
increased from 18.46 nm to 33.37 nm after functionalization with dendrons (Meikle et al, 
manuscript submitted). 
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The cytotoxicity assay showed that the internalization of dendron-functionalized magnetic 
nanoparticles did not induce any apoptotic or necrotic effect, with excellent cytocompatibility 
(99% viability). The lack of toxicity was further corroborated by the TEM analysis, showing 
no alteration of the cell ultrastructure compared to the controls, and by the analysis of 
proliferation, showing similar population doublings between the magnetised cells and the 
controls. These results are in agreement with those reported by Wang et al. showing that 
functionalisation with carboxybetaine could greatly reduce the cytotoxicity of poly(amido 
amine) (PAMAM) dendrimers [42]. It should be noticed that cytocompatibility of CB-MNP 
was not decreased despite the fact that dendron functionalization greatly increased the 
labelling efficiency and the amount of nanoparticles that were internalized by each cell (Fig. 
8F-G). The amounts of nanoparticles used in this study align with the literature [35] and it 
should be underlined that these doses could efficiently achieve levels of cell magnetization 
suitable for biomedical applications requiring cell drive by magnetic forces, such as rapid 
isolation and loading onto tissue engineering scaffolds: in fact, we analysed only the cells that 
could be separated by an external magnet against the force of gravity, so that insufficiently 
labelled cells would be eliminated. Further, labelling efficiency was similar across an 8-fold 
range of CB-MNP doses, despite a very short incubation time of 30 minutes, indicating that 
even lower doses could be investigated in order to maximize safety in future in vivo studies. 
The lack of any obvious adverse effect was corroborated by the analysis of BMSC 
proliferation that showed the typical, progressive increase in doubling time upon 2 passages 
[36], but with no difference in comparison with control non-labelled BMSC. 
It was interesting to observe that both adipogenic and osteogenic in vitro differentiation 
were significantly enhanced in CB-MNP-labelled cells in comparison with non-magnetized 
control BMSC. Although it is not easy to postulate what could be the reason for this effect, it 
is possible to speculate about a possible mechanism. In fact, CB-MNP treatment caused 
labelled cells to more easily assemble in aggregates that required more forceful disruption for 
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e.g. cell counting and, since in vitro differentiation of BMSC is favoured by close cell-to-cell 
contact, the formation of such multicellular clusters could enhance the degree of BMSC 
differentiation, even when seeded at the same initial density. 
The coupling of MNP with dendrons specifically designed to enhance interactions with the 
cell glycocalyx led to a significant increase in the efficiency of magnetization (80% vs 20%) 
as well as to a significant reduction of the time required, with 60% of the cells being 
effectively magnetized in only 5 minutes of incubation in suspension and the plateau value of 
80% being reached already after 15 minutes. Apart from the greater affinity for the negatively 
charged glycocalix on the cell surface provided by the carboxybetaine moiety, causing more 
rapid and more stable association with the cell membrane and leading to a more efficient 
binding and internalization, another property of dendron functionalization may contribute to 
explaining these results. In fact, a comparative analysis showed that, although both types of 
MNP could form aggregates of similar sizes, dendron-functionalised MNP within aggregates 
were less densely packed (see high-magnification right panels in Figure 8B). Dynamic light 
scattering data published elsewhere have shown that the functionalisation of the surface with 
dendrons improves their polydispersity index (Meikle et al., manuscript submitted). This 
would lead to the formation of more aggregates containing less MNP for equivalent total 
doses, which is expected to increase the collective surface area of the aggregates, hence 
favouring its interaction with the cell surface. TEM showed that this process was not 
accompanied by the formation of a clathrin layer around the invagination areas of the 
plasmalemma (Figure 8) thus suggesting that for both types of MNP internalization was 
driven by macropinocitosis [43]. Such a mechanisms of internalization would emphasise the 
important role played by the glycocalyx in the early interaction of the MNP. 
Primary human BMSC are widely investigated in regenerative medicine, both in pre-
clinical research and in clinical trials, because of their recognized potential for differentiation 
in multiple mesenchymal lineages, as well as favourable immunomodulatory properties and 
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paracrine effects that can stimulate endogenous repair mechanisms [44]. However, their stem 
cell properties are easily lost during culture and their ability to regenerate tissue in vivo is 
rapidly jeopardized by in vitro expansion [28,29,36]. Therefore, it is desirable to minimize in 
vitro progenitor manipulation before in vivo delivery in order to maximize their therapeutic 
benefit. To this end, the intraoperative production of tissue-engineered grafts, i.e. the isolation 
of multipotent progenitors from a patient, their seeding on an appropriate scaffolding material 
and their re-implantation in a single-step procedure directly in the operating room, is an 
actively pursued strategy [45,46]. Magnetic scaffolds have been recently developed [47,48] 
and indeed magnetization can be exploited to rapidly and consistently drive cells prior to their 
transplantation. As a perspective in this direction, which should be further investigated in 
future experiments, the results we presented here offer a potential strategy for intraoperative 
magnetic labelling of BMSC without the need for plastic adhesion culture. 
CONCLUSIONS 
The present study shows how the surface functionalization of poly(acrylic acid)-coated 
MNP with a highly branched poly(epsilon-lysine) dendrimer can increase the magnetization 
of human BMSC in a short time when cells are in suspension. The design of the dendron 
allowed the high-density exposure of a highly hydrophylic moiety (carboxybetaine) to the 
MNP surface that is likely to favour the interaction with the cell glycocalyx. While 
cytotoxicity, proliferation and differentiation tests showed no significant adverse effects of 
dendron-functionalised MNP, the presence of the dendron showed a clear improvement in the 
magnetisation process of the cells when in suspension and ultrastructural studies showed how 
their localization in relatively low endosomes did not alter the inner organization of the 
cytosol. These findings provide evidences that ad hoc design of MNP surface 
functionalization can indeed ensure a safer, more reliable and more effective magnetization of 
human BMSC as a means of their manipulation in biotechnological and biomedical 
applications. 
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FIGURE LEGENDS 
Figure 1. MNP design and characterization 
 (A) Schematic representation of PAA-MNP and CB-MNP design and production; (B-C) 
FTIR characterization of CB-MNP (B) and PAA-MNP (C): red arrows indicate the typical 
amine I and amine II peaks of the dendrons. 
Figure 2. BMSC labelling with CB-MNP and dose-dependent cytotoxycity 
(A) BMSC labelling procedure: cell suspensions were aliquoted in a 50mL tube with CB-
MNP (STEP1); cell suspension was incubated at 37°C on an orbital shaker for different times 
(STEP2); magnetized cells were isolated applying an external magnetic field for 10min 
(STEP 3); magnetized cells were seeded on tissue culture dishes for further evaluations 
(STEP 4). (B-C) Representative images of CB-MNP-labeled BMSC with large amounts of 
nanoparticles visible on cell membranes (red arrows in B) and much smaller aggregates 
visible in the culture dish not associated with cells (white arrows in C). (D) Cytotoxicity was 
assayed 24, 48 and 72 hours after labelling with three different concentrations of CB-MNP 
(low = 21.6 µg/ml for 3 x 104 cells; medium = 43.2 µg/ml for 3 x 104 cells; high = 86.4 µg/mL 
for 3 x 104 cells); n=3; p=n.s. for all comparisons. 
Figure 3. In vitro BMSC proliferation after labelling with CB-MNP 
Proliferation speed was measured as the number of population doublings/day over 2 passages 
for control BMSC (not magnetized, CTRL) and for BMSC labelled with the low, medium and 
high concentrations of CB-MNP; n=3, p=n.s. for all comparisons. 
Figure 4. In vitro adipogenic differentiation of CB-MNP-labelled BMSC. 
(A) Representative fields of Oil Red O staining and (B) quantification of Oil Red O staining 
of BMSC cultured in control (Ctrl) or adipogenic medium (Adipo), for control BMSC (not 
magnetized, Ctrl) and for BMSC labelled with the low, medium and high concentrations of 
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CB-MNP. Results are expressed as the mean ± SEM and normalized to the adipogenically 
differentiated control BMSC; n=3; ** p < 0.01 *** p < 0.001. Size bar = 200 µm. 
Figure 5. In vitro osteogenic differentiation of CB-MNP-labelled BMSC 
(A) Representative fields of Alizarin Red staining and (B) quantification of total calcium 
deposited of BMSC cultured in control (Ctrl) or osteogenic medium (Osteo) for control 
BMSC (not magnetized, Ctrl) and for BMSC labelled with the low, medium and high 
concentrations of CB-MNP. Results are expressed as the mean ± SEM; n=3; *** p < 0.001. 
Size bar = 200 µm. 
Figure 6. CB functionalization allows fast and efficient BMSC labelling 
Quantification of the percentage of labelled BMSC after incubation with CB-MNP or PAA-
MNP for 5, 15 or 30 minutes. Results are expressed as mean ± SD; n=3; *** p < 0.001. 
Figure 7. Confocal microscopy analysis of MNP cellular localization after labelling 
Representative z-stack images of BMSC after 30 minutes of labelling with CB-MNP (A) or 
PAA-MNP (B). BMSC were stained with anti-CD90 antibody (red) that marks the cell 
membrane, while nanoparticles were visualized by autofluorescence in the green channel. 
Left panels show a 3D reconstruction of all the confocal optical sections and the white square 
identifies the region magnified on the orthogonal projections on the right panels; size bars = 5 
µm. 
Figure 8. TEM analysis of MNP internalization 
(A-E) Representative transmission electron microscopy images of naïve non-magnetized 
BMSC (A) or after labelling with CB-MNP (B-C) or PAA-MNP (D-E) for 5 or 30 minutes; N 
= nucleus, Cy = cytoplasm, scale bar = 2µm. Arrows indicate extracellular MNP aggregates; 
arrowheads indicate nanoparticles that have been internalized in vacuoles/endosomes. The 
white squares identify the regions magnified on the right panels. (F) Quantification of the area 
occupied by PAA-MNP or CB-MNP in each intracellular vacuole after 5 or 30 minutes of 
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labelling. (G) Quantification of the number of intracellular vacuoles/image containing PAA-
MNP or CB-MNP after 5 or 30 minutes of labelling. 








